Table 1.
Participant Characteristics
| Variables | Included | Excluded | P Value |
|---|---|---|---|
| Sample size | 375 | 227 | |
| Women, n (%) | 204 (54) | 135 (59) | 0.2 |
| Age, y | 72 to 94 | 72 to 97 | 0.1 |
| Height, cm | 169±9 | 168±10 | 0.2 |
| Weight, kg | 77±14 | 77±14 | 0.6 |
| Body surface area, m2 | 1.87±0.20 | 1.87±0.20 | 0.9 |
| Body mass index, kg/m2 | 26.8±4.0 | 27.4±4.3 | 0.1 |
| Heart rate, min−1 | 63±10 | 65±11 | 0.046 |
| Blood pressure, mm Hg | |||
| Systolic | 141±19 | 143±21 | 0.2 |
| Diastolic | 64±9 | 65±11 | 0.1 |
| Mean | 94±11 | 96±13 | 0.051 |
| Peripheral pulse pressure | 77±18 | 78±19 | 0.7 |
| Central pulse pressure | 78±24 | 79±26 | 0.6 |
| Carotid‐femoral PWV, m/s | 13.5±4.7 | 13.8±5.0 | 0.5 |
| Glucose, mmol/L | 5.6±0.8 | 5.6±0.9 | 0.5 |
| HbA1c, %* | 5.7±0.5 | 5.7±0.6 | 0.2 |
| Total cholesterol, mmol/L | 5.3±1.1 | 5.3±1.2 | 0.7 |
| HDL cholesterol, mmol/L | 1.6±0.5 | 1.6±0.4 | 0.4 |
| Triglycerides, mmol/L | 1.2±0.5 | 1.1±0.5 | 0.4 |
| Medical history, n (%) | |||
| Diabetes | 39 (10) | 21 (9) | 0.6 |
| Treated hypertension | 267 (71) | 175 (77) | 0.1 |
| Statin use | 148 (39) | 90 (40) | 1.0 |
| Cardiovascular disease | 79 (21) | 76 (33) | 0.001 |
| Current smoker | 24 (6) | 20 (9) | 0.3 |
HbA1c indicates hemoglobin A1c; HDL, high‐density lipoprotein; PWV, pulse wave velocity.
*
372 cases.